SMN1產(chǎn)品信息
英文名稱:Survival Motor Neuron 1
中文名稱:運(yùn)動(dòng)神經(jīng)元存活蛋白
靶點(diǎn)別稱:SMN1
物種:Human
標(biāo)簽:His Tag
屬性:Protein
標(biāo)記:Unconjugated
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human SMN1, His Tag (SM1-H5145) is expressed from E. coli cells. It contains AA Ala 2 - Asn 294 (Accession # Q16637-1).
Predicted N-terminus: Met
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 33.7 kDa. The protein migrates as 36-40 kDa and 69 kDa under reducing (R) condition (SDS-PAGE).
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, 0.5 M Arginine, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
SMN1主要由位于5q染色體端粒部分的SMN1基因產(chǎn)生。SMN1蛋白是一組稱為SMN復(fù)合物的蛋白質(zhì)之一,它對(duì)維持稱為運(yùn)動(dòng)神經(jīng)元的特殊神經(jīng)細(xì)胞很重要。在細(xì)胞中,SMN復(fù)合體在處理mR中起著重要作用。SMN復(fù)合體有助于組裝處理前mR所需的細(xì)胞機(jī)制。SMN復(fù)合物對(duì)于神經(jīng)細(xì)胞(稱為樹突和軸突)的特殊生長(zhǎng)發(fā)育也很重要。SMN1基因的缺失或突變導(dǎo)致全長(zhǎng)SMN蛋白水平降低,并在人類中表現(xiàn)為一系列神經(jīng)肌肉表型,如脊髓性肌萎縮癥(SMA)。
關(guān)鍵字: SMN1;SMN1蛋白;SMN1重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。